Comparative Effectiveness of Enoxaparin versus Dalteparin for Thromboprophylaxis after Traumatic Injury.

about

Comparative Effectiveness of Enoxaparin versus Dalteparin for Thromboprophylaxis after Traumatic Injury.

Item

http://www.wikidata.org/entity/Q38639944

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Comparative Effectiveness of E ...... ylaxis after Traumatic Injury.

@en

type

Item

label

Comparative Effectiveness of E ...... ylaxis after Traumatic Injury.

@en

prefLabel

Comparative Effectiveness of E ...... ylaxis after Traumatic Injury.

@en

P1476

Comparative Effectiveness of E ...... ylaxis after Traumatic Injury.

@en

P2093

Adam Cuker

http://www.w3.org/2001/XMLSchema#string

Amy T Makley

http://www.w3.org/2001/XMLSchema#string

Brian Smith

http://www.w3.org/2001/XMLSchema#string

Niels Martin

http://www.w3.org/2001/XMLSchema#string

Sean Hennessy

http://www.w3.org/2001/XMLSchema#string

Wensheng Guo

http://www.w3.org/2001/XMLSchema#string

P2860

Thromboprophylaxis for trauma patients

Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations

The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care

Dalteparin versus Unfractionated Heparin in Critically Ill Patients

Thromboembolism after trauma: an analysis of 1602 episodes from the American College of Surgeons National Trauma Data Bank.

Acquired thrombotic risk factors in the critical care setting.

Predictors of posttraumatic deep vein thrombosis (DVT): hospital practice versus patient factors-an analysis of the National Trauma Data Bank (NTDB).

Dalteparin versus Enoxaparin for the prevention of venous thromboembolic events in trauma patients.

Biology of tissue factor pathway inhibitor.

P304

133-142

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CHEST.2017.08.008

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

153

http://www.w3.org/2001/XMLSchema#string

P50

Jason D Christie

Todd Miano

P577

2017-08-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28823757

http://www.w3.org/2001/XMLSchema#string

P932

5812768

http://www.w3.org/2001/XMLSchema#string